Skip to Content
Full Title A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Protocol Number QRK306
clinicaltrials.gov https://clinicaltrials.gov/show/NCT02610296
Principal Investigator(s) David P Foley, MD
Division Transplantation
Status Recruiting
Description

The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors >45 years after brain death (DBD).

Other Clinical Trials in the Department of Surgery
webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System